The QualityStocks Daily Tuesday, May 21st, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(BDRX) $2.3300 +83.46%

CannabisNewsWire(GTVH) $0.0011 +57.14%

QualityStocks(MMAT) $3.3000 +43.48%

The QualityStocks Daily Stock List

Meta Materials (MMAT)

Schaeffer's, QualityStocks, InvestorPlace, MarketClub Analysis, MarketBeat, TipRanks and The Stock Dork reported earlier on Meta Materials (MMAT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Meta Materials Inc. (NASDAQ: MMAT) is a smart materials and photonics firm that is engaged in the invention, design, development and manufacture of different functional materials and nanocomposites.

The firm has its headquarters in Dartmouth, Canada and was incorporated in 2021, on June 23rd by Themos Kallos and George Palikaras. It operates as part of the materials sector, under the chemicals sub-industry and serves consumers across the globe.

The enterprise specializes in the manufacture of highly functional films that have been engineered at the nanoscale to harness electromagnetic waves and the power of light. Its technology platform comprises of 3 core capabilities, namely wireless sensing, lithography and holography. This allows the enterprise to develop a library of functional prototypes and solutions at lower costs and at a much faster pace than traditional chemical synthesis. The enterprise serves the 5G communications, health and wellness, consumer electronics, clean energy, aerospace and defense and automotive industries across the globe and has sales as well as research and development offices in the Silicon Valley and London.

The company’s sustainable higher performance multi-use products employ the use of lightweight raw materials and processes to provide superior performance and consume less energy. Its products include a holographic optical component known as holoOPTIX; a revolutionary transparent conductive film dubbed NANOWEB; and a laser glare protection eyewear known as metaAIR. In addition to this, the company also develops Glucowise.

The firm recently concluded a project to develop a non-invasive glucose sensing prototype which can accurately predict changes in glucose level in diabetes patient. The prototype eliminates the need to draw blood in order to measure glucose levels. Its success will not only benefit patients with diabetes but also extend the firm’s consumer reach, which will be good for investments.

Meta Materials (MMAT), closed Tuesday's trading session at $3.3, up 43.4783%, on 41,281,323 volume. The average volume for the last 3 months is 8.105M and the stock's 52-week low/high is $1.80/$29.12.

Agriforce Growing Systems (AGRI)

MarketClub Analysis, QualityStocks, StockStreetWire, Broad Street, The Online Investor, StockRockandRoll, ProTrader, PennyStockLocks, Penny Stock 101, MicroCapDaily, MarketBeat, INO Market Report, BUYINS.NET, Awareness Stocks and 360 Wall Street reported earlier on Agriforce Growing Systems (AGRI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Agriforce Growing Systems Ltd. (NASDAQ: AGRI) is an agriculture-focused technology firm that is engaged in the development of facility design and hydroponics-based automated growing systems for growers to cultivate crops in a controlled environment.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2017, on December 22nd. Prior to its name change in November 2019, the firm was known as Canivate Growing Systems Ltd. The firm’s subsidiaries include DayBreak Ag Systems Ltd, West Pender Management Co., AGI IP Co., West Pender Holdings Inc. and Agriforce Investments Inc.

The company is working to transform modern agricultural development via its patent pending automated growing and facility design system. It is focused on delivering financially robust and reliable solutions for high value crops to enterprises and businesses. The company operates in the plant-based nutraceutical, pharmaceutical and other high value crop markets.

The enterprise’s methods are designed to produce locally-grown pesticide-free crops. Its products include an automated growing system dubbed AgriForce which has been designed to optimize crop yields and produce in almost all environmental conditions while eliminating the need to use irradiation and fungicides. The enterprise also provides fertigation and nutrients services; genetics and micro-propagation services; integrated artificial intelligence and automated grow technology solutions, and facility and lighting solutions.

The company is preparing for the commercialization phase of its patent pending facility design and automated growing system, which is bound to bring in more opportunities for investment and growth into the firm, while also boosting its revenues.

Agriforce Growing Systems (AGRI), closed Tuesday's trading session at $0.152, up 17.1538%, on 219,665,617 volume. The average volume for the last 3 months is 14,553 and the stock's 52-week low/high is $0.084/$24.495.

Guardion Health Sciences (GHSI)

BUYINS.NET, QualityStocks, MarketBeat, TradersPro, StreetInsider, StockMarketWatch, StocksEarning, Stock Market Watch, MarketClub Analysis, InvestorPlace and InsiderTrades reported earlier on Guardion Health Sciences (GHSI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Guardion Health Sciences Inc. (NASDAQ: GHSI) (FRA: 0QT1) is a specialty health sciences firm that helps develop and distribute medical foods, in addition to designing medical devices that are used to measure the density of macular pigment. The firm was founded in 2009 by Michael Favish and is based in San Diego, California.

The firm operates in 2 segments; Medical Devices and Medical Foods. The latter segment provides GlaucoCetin, a vision-particular nutritional formulation which protects and supports the optic nerve cells’ mitochondrial function in glaucoma patients and another, Lumega-Z; which is used to restore and replenish the macular protective pigment. GlaucoCetin is also used to improve blood flow in the ophthalmic artery in glaucoma patients.

Guardion Health distributes its products through its website, guardionhealth.com and its sales force. The firm’s medical devices segment has designed a technology, MapcatSF, a device used to measure the optical density of the macular pigment.

The firm’s vision testing diagnostics segments operates under VectorVision, which is involved in the development, manufacture and sale of supplies and equipment for industrial vision testing, real-world vision evaluation and standardized vision tests used by eye doctors. The firm’s medical devices segment designs the CSV-1000, an instrument for early diabetic retinopathy, glare sensitivity, low contrast acuity and contrast sensitivity as well as the CSV-2000, which is a standardized digital contrast device for testing sensitivity.

Guardion Health recently announced their new product, a new energy and vision support drink, with final testing expected to end before mid-2021. This product will enable the firm to move into the Asian markets, starting with China. By accessing international markets, the firm opens itself up to more growth and investments, which could bring good returns for both shareholders and stakeholders.

Guardion Health Sciences (GHSI), closed Tuesday's trading session at $9.2654, up 17.2835%, on 85,476 volume. The average volume for the last 3 months is 157,691 and the stock's 52-week low/high is $5.0102/$10.75.

LM Funding America (LMFA)

StockMarketWatch, MarketClub Analysis, TradersPro, QualityStocks, BUYINS.NET, Marketbeat.com, TraderPower, MarketBeat, The Online Investor, StocksEarning, PennyStockProphet, Buzz Stocks, HotOTC, InvestorPlace, OTCtipReporter, Penny Stock, WealthMakers, Profitable Trader Authority, StockOnion and Penny Pick Finders reported earlier on LM Funding America (LMFA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LM Funding America Inc. (NASDAQ: LMFA) (FRA: 1YJA) is a specialty finance firm that operates through its LM Funding LLC subsidiary. The firm offers funding to non-profit community associations located in Florida as well as in the states of Illinois, Colorado and Washington.

LM Funding America Inc. serves consumers throughout the U.S. and was founded on January 14, 2008. The firm has its headquarters in Tampa, Florida and was established by Carollinn Gould.

The company provides nonprofit community associations a range of financial products that can be customized to meet each association’s financial needs. The firm’s products include the new neighbor guaranty and original product. The original product is comprised of offering funding to associations by buying their purchasing rights under delinquent accounts that have been picked by the associations arising from association assessments that have not been paid. On the other hand, LM Funding America Inc. buys delinquent accounts on different terms that have been tailored to suit an association’s needs, under its new neighbor guaranty program. The firm also offers medical insurance products for international travelers.

LM Funding America Inc. recently launched its IPO through its blank check company LMF Acquisition Opportunities. The firm plans to target businesses in the financial services industry and related sectors, with enterprise values between $250-$500 million. This move will not only boost the parent company’s growth but also allow significant expansion in the sector, which will most likely draw in investors.

LM Funding America (LMFA), closed Tuesday's trading session at $3.27, up 14.7368%, on 1,470,004 volume. The average volume for the last 3 months is 277,632 and the stock's 52-week low/high is $1.632894/$5.82.

Alarum Technologies (ALAR)

RedChip, Stock Hedges, QualityStocks, MarketMovingTrends, PennyStockProphet and FreeRealTime reported earlier on Alarum Technologies (ALAR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alarum Technologies Ltd (NASDAQ: ALAR) (TLV: ALAR) is engaged in the provision of cybersecurity and privacy solutions to consumers and enterprises.

The firm has its headquarters in Tel Aviv-Yafo, Israel and was incorporated in October 1989 by Eitan Bremler, Amir Mizhar, Daniel Shachar and Avi Ben-David. Prior to its name change in January 2023, the firm was known as Safe-T Group Limited. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers around the globe, with a focus on those in Israel, Hong Kong, the United States and the Asia Pacific region.

The company’s cybersecurity solutions comprise of AdBlocker, an iOS application for an ad-free internet experience; ZoneZero MFA, a solution designed to add centralized multi-factor authentication capabilities for various types of internal applications; ZoneZero SDP, a solution based on software defined perimeter and zero trust network access concepts that grant access to applications on a need-to-know basis only; and iShield, a cybersecurity cloud software that protects users from online threats, including phishing, malware, ransomware and others. It also offers SDE, which is designed to unify the various data exchange scenarios of an organization, as well as Proxy solutions, which include data center proxy network cloud services, static and dynamic residential proxy network cloud services, and data collection API cloud services. This is in addition to offering Premium dedicated static residential proxies, a solution that creates a dedicated static IP for each user. The enterprise provides its products through distributors, resellers and internet service providers. It serves finance, healthcare, and retail sectors; and government agencies, commercial and online companies, and educational institutions.

The enterprise’s CEO recently revealed its new direction, noting that they remained focused on becoming a leading provider of enterprise and consumer internet access solutions. This will allow the enterprise to occupy a larger market share while also bringing in additional revenues and investments.

Alarum Technologies (ALAR), closed Tuesday's trading session at $31.43, up 12.25%, on 801,697 volume. The average volume for the last 3 months is 393,922 and the stock's 52-week low/high is $1.95/$32.98.

Clearside Biomedical (CLSD)

MarketClub Analysis, TradersPro, MarketBeat, StreetInsider, InvestorPlace, StockMarketWatch, BUYINS.NET, QualityStocks, Kiplinger Today, Marketbeat.com, The Wall Street Transcript, TraderPower, Schaeffer's, Barchart, The Stock Dork, InvestorsUnderground and InsiderTrades reported earlier on Clearside Biomedical (CLSD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Clearside Biomedical Inc. (NASDAQ: CLSD) (FRA: CLM) is a biopharmaceutical firm that is focused on the development and delivery of therapies that preserve and restore vision for individuals suffering from severe eye ailments that affect the choroid and retina.

The firm has its headquarters in Alpharetta, Georgia and was incorporated in May 2011 by Henry F. Edelhauser, Daniel H. White, Mark Prausnitz, Vladimir Zarnitsyn and Samir Kumar Patel. The firm, which operates as a part of the pharmaceutical manufacturing industry under the health care sector in the biotech and pharma sub-industry, serves consumers across the globe.

The company’s product candidates aim to improve and/or restore visual function mainly by decreasing the macular edema linked to different ailments that affect an individual’s vision. It offers a non-surgical application for dosing drugs to eye tissues like the corneal stroma, trabecular meshwork and the retina.

The enterprise’s pipeline is made up of a triamcinolone suprachoroidal injectable formulation dubbed XIPERE, which has been developed to treat macular edema linked to retinal vein occlusion, diabetic macular edema and uveitis. This is in addition to developing a suprachoroidal injection dubbed CLS-AX, which is currently undergoing a phase 1/2a clinical trial.

The firm recently reported progress in its CLS-AX clinical trial, which is a formulation indicated for wet age-related macular degeneration. The trial showed encouraging results. The success of this treatment will not only be beneficial to the patients who will receive treatments from this drug but also the firm, which will bring in more investors, in turn boosting growth.

Clearside Biomedical (CLSD), closed Tuesday's trading session at $1.49, up 12.0301%, on 905,000 volume. The average volume for the last 3 months is 20,137 and the stock's 52-week low/high is $0.650101/$2.12.

Vislink Technologies (VISL)

StockMarketWatch, QualityStocks, Schaeffer's, The Online Investor, StockRockandRoll, PennyStockLocks, Penny Stock 101, BUYINS.NET, Trades Of The Day, StreetInsider, Moleculin Biotech, MarketBeat, InvestorsUnderground and InvestorPlace reported earlier on Vislink Technologies (VISL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vislink Technologies Inc. (NASDAQ: VISL) (FRA: 15XC) is engaged in the production and distribution of wireless telecommunication equipment such as transmitters, receivers, antennas and amplifiers.

Vislink Technologies Inc. changed its name from xG Technology Inc. in February 2019 and is based in Sarasota, Florida. The firm was founded on August 26, 2002 by Richard L. Mooers, Roger G. Branton and Joseph A. Bobier. Vislink Technologies Inc. serves consumers from Asia, Europe, South and North America and other international markets.

Vislink Technologies develops, manufactures and sells video transmission products under the IMT, RF Central and Nucomm brand names for surveillance markets as well as for the entertainment markets.

The firm also provides microwave radio components, cellular, satellite communication systems and wireless camera systems to national, regional and metropolitan law enforcement agencies, defense organizations and agencies, hosted service providers, live and sports broadcasters, station groups and network owners and broadcasters, under the Vislink brand. Vislink Technologies Inc.’s product portfolio includes an IP satellite data terminal known as AirPro-75; an embedded routing and computing system dubbed SatWare; a dual channel diversity receiver-decoder called ViewBack; an aircraft downlink transmitter dubbed HDX-1100 and an on-camera wireless video transmitter called HCAM.

Vislink Technologies Inc. provides a wide range of high-quality technical solutions. The firm recently received an order valued at over $4 million to supply the U.S. DoD with intelligence, surveillance and reconnaissance receiver accessories and devices, showing just how secure, reliable and high-quality Vislink’s products are.

Vislink Technologies (VISL), closed Tuesday's trading session at $5.3, up 9.5041%, on 111,860 volume. The average volume for the last 3 months is 368,888 and the stock's 52-week low/high is $2.31/$8.26.

Rezolute Inc. (RZLT)

QualityStocks, MarketBeat, FreeRealTime and BUYINS.NET reported earlier on Rezolute Inc. (RZLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rezolute Inc. (NASDAQ: RZLT) is a clinical-stage biopharmaceutical firm that is engaged in the development of transformative therapies for metabolic illnesses linked to chronic glucose imbalance.

The firm has its headquarters in Redwood City, California and was incorporated in 2010, on July 26th by Sankaram Mantripragada, Ho Young Huh and Nevan Charles Elam. Prior to its name change in December 2017, the firm was known as AntriaBio Inc. It operates as part of the pharmaceutical and medicine manufacturing industry under the healthcare sector. The firm has three companies in its corporate family and serves consumers around the globe, with a focus on the United States.

The company develops new, sustained-release injectable therapies. It applies proprietary manufacturing capabilities to well-characterized molecules to create patent-protected therapies which have the potential to improve current standards of care significantly.

The enterprise’s product candidates include a potent and selective plasma kallikrein inhibitor known as RZ402, which is undergoing phase 1 clinical trials testing its effectiveness in treating diabetic macular edema. It also develops an injectable basal insulin dubbed AB101 for type 1 and 2 diabetes, as well as a human monoclonal antibody dubbed RZ358, which is in phase 2b clinical trials evaluating its efficacy in treating a rare pediatric genetic disorder known as congenital hyperinsulinism.

The firm recently released its latest financial results, with its CEO noting that they remained focused on positioning the firm well to achieve its clinical milestones and advance its programs in order to develop alternative treatment options for various indications.

Rezolute Inc. (RZLT), closed Tuesday's trading session at $3, up 6.7616%, on 3,855,755 volume. The average volume for the last 3 months is 9,551 and the stock's 52-week low/high is $0.72/$3.69.

Aldebaran Resources (ADBRF)

QualityStocks and MarketBeat reported earlier on Aldebaran Resources (ADBRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aldebaran Resources Inc. (OTCQX: ADBRF) (CVE: ALDE) is a mineral exploration firm focused on acquiring, exploring for and evaluating mineral properties in Canada and Argentina.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2018, on June 7th. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers around the globe.

The company operates as a subsidiary of Regulus Resources Inc. Its projects include Altar, Rio Grande, Oscara, Aguas Calientes, El Camino, La Frontera, and Catua. It holds 60% interest in the Altar copper-gold project, which hosts a cluster of porphyry deposits in Argentina. It holds 100% interest in Rio Grande, a copper-gold prospect with associated iron-oxide-copper-gold style alteration located in Salta Province, northwestern Argentina. The La Frontera project is a low-sulfidation epithermal style silver-gold prospect. The Aguas Calientes property is located in northwestern Argentina in Jujuy Province. Access from the City of Salta is by all-weather roads and paved highways. The Catua property is located six kilometers from the Chilean border and 220km northwest of the city of Salta. The Oscara project is in the Puna region of the Salta Province in northwestern Argentina. The EI Camino project is located 380km northwest of the City of Salta, northwest Argentina.

The enterprise, which recently expanded mineralization at its Altar copper-gold project, remains focused on growing Altar United and Altar East while also creating new avenues to generate value for its shareholders. This will, in turn, encourage additional investments into the firm.

Aldebaran Resources (ADBRF), closed Tuesday's trading session at $0.81814, off by 7.0295%, on 12,030 volume. The average volume for the last 3 months is 1.57M and the stock's 52-week low/high is $0.40/$0.9004.

atai Life Sciences N.V. (ATAI)

QualityStocks, MarketBeat, The Online Investor, StockMarketWatch, Dynamic Wealth Report, StreetInsider, MarketClub Analysis, Small Caps, Uncommon Wisdom, Marketbeat.com, CRWEWallStreet, PsychedelicNewsWire, CRWEPicks, InsiderTrades, CRWEFinance, BestOtc, DrStockPick, PennyOmega, PennyToBuck, Schaeffer's, StockHotTips, TraderPower, Awareness Stocks, StockOodles, Street Insider, The Street, TopPennyStockMovers, Broad Street and ProTrader reported earlier on atai Life Sciences N.V. (ATAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A few months from now, the U.S. Food and Drug Administration (FDA) will be deciding whether MDMA can be prescribed as a treatment for post-traumatic stress disorder (PTSD”. MDMA, which is commonly known as ecstasy, is currently classified as a Schedule I drug under the Controlled Substances Act.

The agency’s approval of the drug’s use would be a significant breakthrough, particularly for the movement that has championed for psychedelic drugs to be used in managing a range of mental health conditions. On the other hand, FDA rejection of the drug’s use for these conditions would also be a major setback for the movement.

Various trials have demonstrated the drug’s potential for managing symptoms of post-traumatic stress disorder, with testimonies from some individuals who took part in the trials describing the therapy as transformational.

Despite this, some concerns are threatening to hinder the drug’s path into mainstream healthcare. A draft report released about two months ago by the Institute for Clinical and Economic Review (ICER) raised significant concerns about the validity of the findings from trials involving the drug. ICER is a nonprofit that assesses drug prices and clinical trials.

In its report, the nonprofit acknowledged that the data suggested that MDMA would be a crucial addition to treatment options for post-traumatic stress disorder. That said, the report questioned whether the findings told the whole story.

The report was accompanied by a citizen petition to the Food and Drug Administration, with the group of concerned individuals claiming possible ethical violations and misconduct that could compromise research on the psychedelic drug. In its petition, the group asked that the FDA arrange a public meeting to address the issues raised. If these claims are true, the likelihood of MDMA receiving approval from the FDA may reduce greatly.

Organizations at the forefront of research into MDMA also have a lot to lose, among them Lykos Therapeutics and the Multidisciplinary Association for Psychedelic Studies (MAPS). Lykos funded the clinical trials on the psychedelic drug, whose results are included in the company’s application to the federal agency requesting approval to market the medication for therapy-assisted post-traumatic stress disorder treatment.

Scientists and clinicians who were part of the trials have refuted accusations that their clinical data isn’t sound. The lead author of the published findings from MAPS’ phase 3 trials, Professor Jennifer Mitchell of the University of California-San Francisco, stated that she would support the findings.

The trials assessed the effectiveness of MDMA-assisted therapy in treating moderate and severe post-traumatic stress disorder. In their report, the researchers noted that roughly 71% of participants who received the MDMA treatment didn’t meet the diagnostic criteria for post-traumatic stress disorder.

Startups such as atai Life Sciences N.V. (NASDAQ: ATAI) that are conducting their own psychedelic drug-development programs will be watching how these issues leveled against the studies conducted by MAPS will play out and how the FDA rules about the MDMA new drug application.

atai Life Sciences N.V. (ATAI), closed Tuesday's trading session at $1.68, off by 2.8902%, on 960,427 volume. The average volume for the last 3 months is 2.145M and the stock's 52-week low/high is $1.025/$2.85.

Momo Inc. (MOMO)

StocksEarning, MarketClub Analysis, InvestorPlace, Schaeffer's, StockEarnings, QualityStocks, Marketbeat, Market Intelligence Center Alert, The Street, Zacks, Kiplinger Today, Trades Of The Day, StreetInsider, Daily Trade Alert, The Street Report, Marketbeat.com, The Online Investor, BUYINS.NET, INO.com Market Report, FreeRealTime, Trading Concepts, Louis Navellier, TradersPro, Wealth Insider Alert, StreetAuthority Daily, TopStockAnalysts, Money Morning, Investopedia, DividendStocks, Daily Wealth, ChineseWire, PennyDoctor, TipRanks, Greenbackers, StockMarketWatch, StocksImpossible, Street Insider, OTCBB Journal, Early Bird, First Penny Picks, ChartAdvisor, Barchart, CrashTrade, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Video-sharing platform and YouTube competitor Rumble has filed a suit against Google over the leading information technology company’s online advertising activities. According to Rumble, Google has engaged in anticompetitive business practices and secured a monopoly over the digital-advertising space by preventing Meta subsidiary Facebook from providing customers with alternatives to its digital-advertising ecosystem.

Rumble’s lawsuit claims that Google also used its financial might to gobble up potential competitors, granting it a monopoly in both the buying and selling of online ads as well as near total control over the systems that facilitate digital ad buying and selling. The video-sharing platform filed the suit in the U.S. District Court for the Northern District of California last week and is seeking damages worth more than $1 billion.

Google does control a significant portion of the online ad ecosystem thanks to offerings such as Google Adsense and draws a whopping three-quarters of all its revenue from its online ad business. Even so, the tech giant dismissed Rumble’s claims of engaging in uncompetitive practices and said that the video-sharing platform is “simply wrong.” Google argued that Rumble also uses dozens of ad services from competing companies on top of Google AdSense, challenging the notion that Google has monopolized the digital-advertising market.

In a statement issued to Reuters, a Google spokesperson said the company would show the court how its advertising products provided value to publishers and helped them generate funding for their digital content. Furthermore, the spokesperson stressed that publishers who use Google tools retain most of their revenue.

This isn’t the first time Google has attracted Rumble’s legal ire. Rumble first sued Google in 2021 for at least $2 billion for reportedly prioritizing itself and sister company YouTube in its search-engine results, but the lawsuit is still in discovery.

The 2021 suit claimed that Google “diverted massive traffic” to its video-sharing arm YouTube by rigging its search algorithms and deprived Rumble of all the traffic, brand awareness, users, uploads, and revenue the company would have earned. It was also filed at the U.S. District Court for the Northern District of California.

Google is also fielding another 2023 civil antitrust suit from the U.S. Justice Department that claims it has monopolized the search and search-advertising segments and is abusing its digital-advertising monopoly. The U.S. Department of Justice argued that Google should be compelled to split off from its digital-advertising arm.

The issues that Rumble raises in its lawsuit could also be impacting other social-media industry players such as Momo Inc. (NASDAQ: MOMO), and they are likely to see how the court decides this matter when hearings conclude.

Momo Inc. (MOMO), closed Tuesday's trading session at $5.83, off by 3.1561%, on 1,343,457 volume. The average volume for the last 3 months is 3.526M and the stock's 52-week low/high is $5.30/$11.12.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, Kiplinger Today, MarketClub Analysis, StocksEarning, The Street, MarketBeat, QualityStocks, Daily Trade Alert, Trades Of The Day, Wealth Insider Alert, The Online Investor, StockEarnings, Market Intelligence Center Alert, StockMarketWatch, StreetInsider, BUYINS.NET, Zacks, The Wealth Report, Investopedia, Top Pros' Top Picks, Stock Up Featured, Cabot Wealth, InvestmentHouse, Daily Profit, CannabisNewsWire, Early Bird, Jim Cramer, InsiderTrades, The Rich Investor, InvestorsObserver Team, InvestorsUnderground, Money Morning, VectorVest, 24/7 Trader, Small Cap Firm, Stock Gumshoe, TheTradingReport and Wall Street Window reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent survey by a group opposing the legalization of marijuana in Florida reveals that while a majority of voters support the initiative, support falls short of the required 60% threshold for approval. Conducted by Cherry Communications for the Florida Chamber of Commerce, the poll indicates that 58% of Florida’s probable voters favor legalization while 37% oppose it, with 5% undecided.

On the other hand, an alternative ballot item related to abortion rights has 61% of the vote, which means it will probably pass.

This marks the third survey indicating insufficient support for the marijuana initiative since Florida’s Supreme Court greenlighted its inclusion on the ballot, rejecting a challenge from Ashley Moody, the state’s attorney general.

The survey, which involved 609 voters who are likely to vote, was conducted between April 28–May 7, 2024, with a margin of error of 4%.

A recent Ipsos/USA Today poll indicated that 56% of registered voters in Florida and 49% of adults statewide support marijuana legalization. Similarly, only 47% of voters in a Mainstreet Research and Florida Atlantic University (FAU) poll were in favor, with 35% against and 18% undecided.

Notably, Kim Rivers, Trulieve’s CEO, contested the recent polls, asserting that the internal survey suggests strong support for the initiative, potentially exceeding 70%. Trulieve, a major financial contributor to the campaign, has invested close to $50 million.

Although the campaign has not disclosed internal survey data, previous surveys have shown a more positive image. November 2023 saw approximately 70% of respondents to a University of North Florida (UNF) poll in favor of legalization.

Florida governor, Ron DeSantis, anticipates a rejection of the measure in November, citing concerns over its potential impact on the quality of life.

Despite DeSantis’s position, he accurately predicted the Supreme Court’s decision to include the initiative on the ballot. Additionally, he has weighed in on federal marijuana policy, asserting that the federal ban on gun ownership for state-legal cannabis users may be unconstitutional. However, he did not intervene in a lawsuit filed by Florida’s former agriculture commissioner against the Biden administration over this issue.

Economic projections suggest legalization could generate significant tax revenue, estimated between $195 million and $431 million annually. If passed, the initiative would amend Florida’s Constitution to permit existing medical marijuana companies, such as Trulieve, to sell cannabis to adults 21 years of age and older. Notably, the proposal lacks provisions for home cultivation, expungement of past records or social-equity measures. The specifics of the survey questions were not disclosed publicly.

Industry actors such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) will be watching the developments in Florida to see if it becomes the latest U.S. state to end marijuana prohibition.

Cronos Group Inc. (CRON), closed Tuesday's trading session at $2.77, off by 0.3597122%, on 1,616,761 volume. The average volume for the last 3 months is 52,390 and the stock's 52-week low/high is $1.64/$3.14.

The QualityStocks Company Corner

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlightFathom Nutriband Inc. (NASDAQ: NTRB) .

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceuticals and technology, will be spotlighted in an upcoming webinar, hosted by RedChip Companies. The event is slated for May 30, 2024, and will begin at 4:15 p.m. ET. Nutriband chair Serguei Melnik and CEO Gareth Sheridan will present during the event, which will provide key information for investors regarding current operations and upcoming milestones.

To register for the event, visit https://ibn.fm/9REfQ

To view the full press release, visit https://ibn.fm/mH9jC

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico and Australia.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Nutriband Inc. (NASDAQ: NTRB), closed Tuesday's trading session at $4.935, up 1.7526%, on 31,861 volume. The average volume for the last 3 months is 39.145M and the stock's 52-week low/high is $1.53/$6.00.

Recent News

Golden Triangle Ventures Inc. (OTC: GTVH)

The QualityStocks Daily Newsletter would like to spotlight Golden Triangle Ventures Inc. (GTVH).

Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, are positioning for opportunity. "Most recently, the company took a significant step forward in the development of Destino Ranch into a premier music, art destination with the acquisition of ABI Create, an innovative event management and production company. Founded by Marco Antonio Moreno, who was recently named president and COO of Lavish Entertainment, ABI Create has delivered high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions across the United States, including the NFL Super Bowl, San Diego and New York Comic Con events, EDC and Camp EDC, Bonnaroo Music Festival, the Waste Management Phoenix Open, Arnold Palmer Invitational, Burning Man and more… With the invaluable resources ABI Create brings to the table, the future of Destino Ranch looks more promising than ever," a recent article reads. "Our goal is to develop ABI into a one-stop shop, event-management business within Lavish that will hold a complete suite of event management and development services. This aims to complement all internal projects and productions and will potentially support outside business opportunities that can provide fundamental synergies to our ultimate plan of building a complete entertainment enterprise," said Steffan Dalsgaard, CEO of GTVH.

To view the full article, visit https://ibn.fm/ZwcVg

Golden Triangle Ventures Inc. (OTC: GTVH) is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities.

Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces.

The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business.

Health Division – Global Health Services

Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures (operating under its Health Division). Dedicated to the promotion of well-being and natural wellness, the company currently does business in the industrial hemp/CBD industry. Additionally, the company has a vision to promote, market and generate sales for a myriad of products and services which include a full retail line of high-end, all-natural health, wellness and beauty products.

To help achieve this vision, Global Health Services is in the process of further developing an extensive online portal that will support the multiple verticals under the company and provide a one-stop-shop for all of the company’s products and services. Moreover, to support overarching business goals, senior management tirelessly works on acquiring and building an array of profitable assets and projects.

Entertainment Division – Lavish Entertainment

Lavish Entertainment (EpicRaves) is a wholly owned subsidiary of Golden Triangle Ventures under its Entertainment Division. Operating out of Las Vegas, Nevada, the company started doing business in 2017 and was established with a vision of becoming a nationally recognized concert production company. The company currently has more than 30,000 national followers and nearly 100 team members who have helped the company successfully organize some of the most exciting Electronic Dance Music concerts in Las Vegas.

Lavish Entertainment is currently doing business as EpicRaves, which will eventually become a wholly owned subsidiary of Lavish Entertainment as the company expands its business into a variety of other forms of entertainment. The company is currently building a unique virtual reality platform to help expand on its live events, and it is working to acquire a 68,000 sq. ft. event center with a vision to develop one of the most advanced event centers in the world.

Technology Division – HyFrontier Technology

HyFrontier Technologies is a wholly owned subsidiary of Golden Triangle Ventures under its Technology Division. The company owns a patent-pending process and device technology called HyGrO, which is a molecular hydrogen and oxygen delivery system for agriculture. Golden Triangle Ventures is assisting the company in commercializing the HyGrO unit for farm and home use in markets across the globe. HyFrontier Technologies has a mission to improve global crop production efficiency by producing hydrogen and oxygen directly in the water stream.

This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations and small farms or utilized for a multitude of residential home and garden applications. In-house testing has shown evidence that hydrogen is capable of increasing crop yields by up to 25% and, in many circumstances, a much higher amount. Larger root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Universities and multiple third-party testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive.

To push the development and commercialization of the technology, management is now in the process of moving the company headquarters from Colorado to Florida, which will transition its operations into a 7,800 sq. ft. state-of-the-art manufacturing facility. The company recently executed a three-year lease with an option to purchase the entire 24,000 sq. ft. building, which will help the business in achieving its ultimate goal of commercializing this technology to the world.

Food & Wine Division – Napa Wine Brands

Napa Wine Brands is a wholly owned subsidiary of Golden Triangle Ventures which is a synergistic business with a mission of providing a world-class portfolio of unique brands birthed from Napa Valley and Sonoma Valley in the heart of California’s Wine Country.

The company has a commitment to manufacture and distribute specialty wines, foods and unique items while tapping into an array of hidden markets in the food and beverage industry. With extensive resources and award-winning products, Napa Wine Brands aims to develop some of the most desirable products in today’s market. Originated by some of the most profound experts in Napa Valley, the company’s vision is to broaden the horizon of a traditional food and wine company by creating a platform different than anything seen in the Northern Hemisphere.

Napa Wine Brands has an array of fully developed products and services that provide value to the other divisions under Golden Triangle Ventures. The company is now preparing the launch of several brands, products and services that are market-ready and will immediately turn into cash-positive businesses. Golden Triangle Ventures will provide a full support system and assist management of Napa Wine Brands in growing this company into another fun, exciting and profitable division of Golden Triangle Ventures.

Recent Updates

  • On May 26, 2021, Golden Triangle announced its acquisition of The Lodge Winery & Olive Oil Co. under the company’s Napa Wine Brands subsidiary. The Lodge Winery & Olive Oil Co. is an established wine brand that produces award-winning wines, olive oils and wine vinegars. “Our marketing team is now ready to launch an in-depth program focused on driving our products into big box stores, smaller retail outlets, online platforms and many other avenues,” Steffan Dalsgaard, CEO of Golden Triangle, stated in a news release announcing the acquisition. “We are working directly with [Napa Wine Brands CEO] Arron [Johnson] and his team to grow their bulk inventory and launch all of these products for the world to enjoy.”
  • On May 20, 2021, Golden Triangle announced its entry into a letter of intent to acquire Sonder Fulfillment LLC, a leader in the industrial hemp and CBD space that is dedicated to driving forward the most powerful and efficacious cannabinoid products in the world. “Over the past two years, our operating partners have compiled a team of the best minds in the industrial hemp industry to create a totally vertical operation from seed to shelf,” Joshua Weaver, CEO of Sonder Fulfillment, stated in a news release announcing the LOI. “This acquisition by Golden Triangle Ventures will fully capitalize our operations and allow us to further expand our product lines and enter into new markets across the globe.”
  • On May 19, 2021, Golden Triangle announced the execution of a formal agreement with Robert “Bo” DuBose to purchase the remaining 49% of HyFrontier Technologies Inc., giving Golden Triangle 100% ownership of the technology company. “This acquisition has been something that Bo and I have been working towards for quite some time and we are both incredibly happy to have this executed,” Dalsgaard stated in a news release announcing the acquisition. “We knew that completing this agreement would show the world that we are both fully committed to our shareholders and the brilliant future of this revolutionary company.”
  • On May 12, 2021, Golden Triangle announced its acquisition of a top tier, professional sound system and formed a partnership with SuperKollider Sound LLC to provide a strategic benefit to the company’s entertainment division under Lavish Entertainment Inc. “We are very excited to acquire this unbelievable sound system,” Dalsgaard stated in a news release announcing the acquisition. “Hennessey Sound Design has always been one of my favorite systems on the market, and the team at SuperKollider Sound are true professionals in this space.”

Management Team

Steffan Dalsgaard is the Founder & Executive Chairman of Golden Triangle. He has a background in business development, with over a decade of experience representing and consulting with dozens of private and public companies. Mr. Dalsgaard consults with companies on all of their corporate objectives while providing a professional and corporate face to their organizations. He has built a strong reputation in the public relations industry and has a mission to work with emerging growth companies that are positioned to become significant businesses in their respective fields.

Robert DuBose is the company’s Chief Innovations Officer & Director and the CEO of HyFrontier Technologies Inc. Mr. DuBose is responsible for the success of the HyGrO product in the agricultural market. His experience in the design and production of hydrogen equipment goes back more than a decade, including PEMFC technologies since 2009 with his company, Aquafuel Inc. Mr. DuBose was raised in the farming and machine shop business, where he learned firsthand how much work and love goes into a successful crop, as well as how elements, which are out of the farmers control, can have adverse effects on finances. His belief that being able to deliver a solution to increase growth, yield, health, stamina of crops and profitability for farmers would be a win-win for all led him to create the HyGrO product.

Stuart Seim is the Chief Development Officer & Director of Golden Triangle. He began his career as an associate professor at the University of Manitoba in the field of outdoor and environmental education after receiving his master’s degree and completing advanced educational studies. Coming from a family with an extensive financial background, Mr. Seim became a stockbroker for major regional financial firm Robert W. Baird. In a short time, he became the Branch Manager for Baird in Minneapolis, Minnesota, while also serving as a Managing Director for Baird. During this time, Mr. Seim also served on the board of an industrial hearing company, which he helped to launch as a new company (The TK Group). Mr. Seim currently resides in Colorado, where he is an advisor to several organizations.

Golden Triangle Ventures Inc. (GTVH), closed Friday's trading session at $10.83, up 4.4359%, on 81,689 volume with 697 trades. The average volume for the last 3 months is 269,609 and the stock's 52-week low/high is $2.33999991/$20.0783996.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

Astiva Health is a leading healthcare provider that specializes in delivering personalized and comprehensive healthcare solutions to diverse communities. "Astiva Health is dedicated to enhancing the quality of medical care through a strong doctor-patient relationship with the success of its model hinging on knowledgeable, competent and hard-working primary care physicians (‘PCPs') who play a pivotal role in the healthcare system… Astiva Health is dedicated to establishing a healthcare ecosystem where the best primary care doctors are not only rewarded for their expertise but also for their commitment to providing the best possible care… In addition, Astiva Health collaborates with more than 60 physician groups with a focus on empowering PCPs to excel by allowing them more time for patient interactions through the strategic use of technology… The company is also dedicated to simplifying processes for doctors, achieving an impressive approval rate for requests, and significantly reducing review times," a recent article reads. "Finally, Astiva Health actively works with its patients to facilitate more frequent doctor visits, supporting a model that rewards physicians for top-tier primary care services. By aligning incentives and employing a unified system for doctor-patient interactions, Astiva Health fosters a proactive environment where primary care thrives, ultimately benefiting the overall health and well-being of patients."

To view the full article, visit https://ibn.fm/FnyrZ

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company exploring for high-grade copper and gold deposits in Virginia and Nunavut, Canada, is providing an update regarding drilling activities at its Storm Copper Project, located on Somerset Island, Nunavut. According to the announcement, successful exploration indicates potential for "rapid and significant expansion," and the operator of the project, America West Metals Limited, has completed the necessary expenditures to earn an undivided 80% interest in the project. Specifically, the report noted that 2024 reverse circulation ("RC") drilling has delivered immediate success in intersecting thick new zones of copper mineralization in the drilling of geophysical targets, and the visual copper sulfide mineralization intersected in SR24-03 and SR24-04 is much like high-grade copper mineralization in the 2023 discovery hole at the nearby Thunder Prospect, which returned 48.6 meters @ 3% copper ("Cu"). The company noted that drilling results continue to show a strong correlation between moving loop electromagnetic ("MLEM") targets and copper mineralization, with an extensive suite of new geophysical targets prioritized for drilling in 2024. The company has sent samples for the first batch of drilling to the laboratory and expects to receive assay results in the coming weeks. In addition, phase 1 of the MLEM surveys have been completed in the Storm area and the deep search phase of the program now underway while drilling by the track-mounted RC rig is continuing 24/7. "It is very encouraging to report early success from the 2024 exploration program at Storm," said Aston Bay CEO Thomas Ullrich in the press release. "Drilling of Moving Loop EM geophysical anomalies is proving to be very effective at discovering copper mineralization. This provides a powerful exploration advantage. With several new anomalies still to be drilled and deep potential only now being tested by this method, we are excited for the potential for continued discovery this season at Storm."

To view the full press release, visit https://ibn.fm/FPFE2

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Tuesday's trading session at $0.096, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0225/$0.2474.

Recent News

GEMXX Corp. (OTC: GEMZ)

The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .

In an expansion of operations, GEMXX plans to finance the exploration of extensive oil reserves, specifically targeting giant fields with reserves of 500 million barrels and super-giant fields with over 3 billion barrels located primarily in Latin America

By leveraging a comprehensive network in the oil and gas sector, GEMXX plans to develop strong strategic partnerships and secure funding to propel exploration efforts quickly

GEMXX has also announced Richard Clowater as the new Chief Executive Officer and Chairman of the Board, and the appointment of Deane Preston to its Board of Directors, effective May 15, 2024

GEMXX (OTC: GEMZ), an established mine-to-market gem enterprise, has announced that the company is actively broadening its business framework to incorporate private equity funding for oil and gas ("O&G") exploration ventures. With a large network of global relationships and several strategic alliances recently established, GEMXX is setting the stage to finance the exploration of extensive oil reserves, specifically targeting giant fields with reserves of 500 million barrels and super-giant fields with over 3 billion barrels located primarily in Latin America (https://ibn.fm/gi2e3).

GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.

As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.

One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.

Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.

GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.

The company has offices in Las Vegas and Hong Kong.

Projects and Operations

GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.

Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.

Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.

To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.

 

GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.

Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.

Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.

In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.

Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.

Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.

By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.

Market Opportunity

Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.

Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.

Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.

Management Team

With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.

Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.

Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.

Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities. 

P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.

GEMXX Corp. (OTC: GEMZ), closed Tuesday's trading session at $0.02985, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0172/$0.20.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Marijuana companies, state regulators, hemp businesses, prohibitionists and Congressional lawmakers are all scrambling to see their priorities addressed in the upcoming farm bill. While there are some points of agreement by various groups, the points on which they differ are generating measurable tension. For example, hemp industry actors are disturbed that some marijuana companies have allied with prohibitionists to see some hemp derivatives outlawed. Edward Conklin, executive director of the United States Cannabis Council ("USCC"), sent a letter to select Congressional leaders in April. He indicated that it was complicated to make policy changes regarding hemp and requested that urgent attention be directed toward addressing the loopholes seen in the definition of hemp. He added that Congress needed to create a pathway through which nonintoxicating cannabinoids from hemp can be regulated. Jonathan Miller, the roundtable's general counsel, added that some companies and organizations within the marijuana space view intoxicating hemp products as competing with what they sell. Such people aren't pleased that marijuana is more heavily regulated while those intoxicating hemp products aren't. Additionally, many marijuana entities are becoming involved in the hemp space, so the view that prohibition isn't the way to go is the right one. Clarity on the future of the regulatory landscape for different hemp or marijuana-derived cannabinoids would help many companies such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) to plan better regarding their strategic direction and expansion plans.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Tuesday's trading session at $0.013, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

ECGI Holdings Inc. (OTC: ECGI)

The QualityStocks Daily Newsletter would like to spotlight ECGI Holdings Inc. (OTC: ECGI).

ECGI Holdings is a diversified holding company with a distinctive portfolio comprising viticulture and luxury brands

The company in 2023 made a strategic investment in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories

In 2024, ECGI Holdings' 40-acre Lake County, California, property was approved by Evolve vacation rental management as Vintner's Caldera Ranch, a luxurious short-term rental destination

In 2024, the company introduced Pacific Saddlery's new mobile retail boutique at specific equestrian events as a highlight of its future outlook

ECGI Holdings (OTC: ECGI) is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating the Petite Sirah varietal, known for its bold and rich character, aligning with the growing demand for unique and high-quality wine experiences.

ECGI Holdings Inc. (OTC: ECGI) is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating the Petite Sirah varietal, known for its bold and rich character, aligning with the growing demand for unique and high-quality wine experiences.

In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI Holdings’ commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle.

Moving forward, ECGI Holdings is focused on identifying and capitalizing on growth opportunities that align with the company’s business objectives and continuing to improve its financial structure. In 2024, ECGI Holdings was approved by Evolve — a distinguished name in vacation rental management. This partnership will transform the company’s 40-acre Lake County property into a luxurious short-term rental destination aptly named Vintner’s Caldera Ranch.

ECGI Holdings is excited about the possibilities that Vintner’s Caldera Ranch creates for shareholders and looks forward to further developments poised to unlock the value of other underutilized assets. The company believes that it is laying a solid foundation for sustained success and profitability in the years to come.

ECGI Holdings is headquartered in Irvine, California.

Operational Philosophy

ECGI Holdings has embarked on an ambitious new vision and strategic direction to build and nurture luxury brands that resonate with its core values and market aspirations. Its joint venture with Pacific Saddlery epitomizes ECGI Holdings’ strategic shift toward luxury branding, leveraging Pacific Saddlery’s tangible and established market presence in equestrian products.

This transition will also allow ECGI Holdings to explore new pathways to monetize its underutilized assets, including the company’s vineyard. A key highlight of the company’s future outlook is the debut of Pacific Saddlery’s new mobile retail boutique at specific equestrian events in 2024. This innovative venture represents a significant step in ECGI Holdings’ strategy to enhance brand visibility and engage directly with the company’s target market.

In addition, the Vintner’s Caldera Ranch development marks a significant step in advancing the company’s strategy to revitalize and leverage underutilized assets. Vintner’s Caldera Ranch is set against the backdrop of Lake County’s breathtaking scenery, offering an exclusive getaway experience that blends natural beauty with luxury. Choosing Evolve is a strategic move to ensure that Vintner’s Caldera Ranch not only meets but exceeds the high standards of service that luxury guests expect.

Evolve’s expertise in maximizing rental potential and delivering exceptional guest experiences is crucial to the company’s vision of making Vintner’s Caldera Ranch a preferred choice for discerning travelers. With this venture, ECGI Holdings is not only expanding its footprint within the luxury rental marketplace, but also contributing to the local economy and enhancing the appeal of Lake County as a tourist destination.

The company’s focus remains steadfast on strategic growth, operational excellence and customer satisfaction.

Market Outlook

A report from Grand View Research, a global market research and consulting company, estimated the value of the worldwide luxury brands market at $366.23 billion in 2023 and projects the market to grow to a value of $580.43 billion by 2030, achieving a CAGR of 6.8% over the forecast period.

Rising disposable income and wealth in various regions of the world, particularly in emerging markets such as China and India, have propelled the growth of the market, according to the report.

Younger consumers, such as millennials and Generation Z, are increasingly entering the luxury market, driving demand for more contemporary and experiential luxury offerings. The rise of social media and influencer marketing has greatly impacted the visibility and desirability of luxury products, the report states.

Management Team

Jamie Steigerwald is CEO of ECGI Holdings, Inc. He is a successful entrepreneur with over 30 years of experience. Most recently, he was COO of Sugarmade Inc. (OTC: SGMD), a California cannabis real estate, cultivation, manufacturing and services company. He is the owner of SwiftLead, an Orange County web marketing, design and development company. He previously was COO for First USA Home Loans, a retail mortgage lender, and co-founder and President of SwiftLead Software, a mortgage lead tracking system.

Nick Collins is CEO at Pacific Saddlery. He brings over 25 years of expertise in equestrian luxury goods. He previously founded Rolling Meadows and created the Allon Equestrian and Renard et Cheval apparel brands. He was instrumental in creating and launching Kaval.com, an online equestrian apparel and accessories site.

ECGI Holdings Inc. (OTC: ECGI), closed Tuesday's trading session at $0.0022, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0016/$0.0198.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software, and services, will present at this month's Reuters Supply Chain USA 2024 conference, which is slated for May 22–23, 2024, in Atlanta. During the conference, D-Wave VP of quantum technology evangelism Murray Thom will speak about quantum computing's role in addressing optimization challenges facing the supply chain and how this emerging technology can help organizations maintain adaptability in the face of persistent disruption.

"Quantum computing holds the key to solving some of the most intricate optimization challenges faced by supply chain executives," said D-Wave chief revenue officer Lorenzo Martinelli in the press release. "We're excited to bring quantum to the conversation at Reuters Supply Chain USA 2024 and share valuable insights of how our customers are using our technology to achieve a more agile, resilient, optimized and sustainable supply chain."

To view the full press release, visit https://ibn.fm/gJKGt

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Tuesday's trading session at $1.24, off by 5.3435%, on 2,268,785 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.4996/$3.20.

Recent News

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)

The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

An online identity startup that uses blockchain tech to verify the online identities of individuals through palm scanning has bagged $30 million in seed capital. The startup, Humanity Protocol, is currently valued at $1 billion.

The seed round was led by Kingsway Capital, an investment-management company based in the United Kingdom. Various Web3 investment companies participated in the event, including Blockchain.com and Animoca Brands. hima Capital, a venture company, also took part in the event. Despite these hitches, Kwok is of the opinion that biometrics tech has matured over the last few years, with Apple also incorporating FaceID within its smartphones. According to Humanity Protocol's CEO, the company's approach is hardly invasive in how it verifies one's identity, adding that their method is less dystopian. The company remains committed to safeguarding individuals' rights while also creating a more secure and equitable online environment for all. Entities such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) that are involved in sensitive segments such as healthcare ecommerce have turned to Web3 solutions for the same reason of ensuring an equitable and safe experience for all using their platforms.

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Alibaba.com Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Tuesday's trading session at $1.14, off by 5%, on 138,286 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.116/$3.12.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Clene presented clinical data at the 2024 American Academy of Neurology ("AAN") Annual Meeting, demonstrating that long-term CNM-Au8® treatment resulted in significant evidence of repair and remyelination across multiple paraclinical endpoints

Clene entered into a sub-award grant agreement with Columbia University under the previously announced National Institute of Health ("NIH") Grant

Clene announced the publication of "Protein Corona Composition of Gold Nanocatalysts" in the ACS Pharmacology & Translational Science journal

Clene (NASDAQ: CLNN), a late-stage clinical biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis ("ALS") and multiple sclerosis ("MS"), along with its wholly-owned subsidiary Clene Nanomedicine, Inc., recently announced its first quarter 2024 financial results and provided an important update on the CNM-Au8 clinical program for MS (https://ibn.fm/hfocz).

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Tuesday's trading session at $0.37, off by 0.5376344%, on 207,227 volume. The average volume for the last 3 months is 872,104 and the stock's 52-week low/high is $0.25/$1.09.

Recent News

Torr Metals Inc. (TSX.V: TMET)

The QualityStocks Daily Newsletter would like to spotlightFathom Torr Metals Inc. (TSX.V: TMET) .

Central banks bought 290 metric tons of gold during Q1 2024, while copper prices continue to climb as part of the green energy transition

Torr Metals has three highly prospective Canadian gold and copper projects including Kolos, a major intrusive complex considered the last remaining to be tested in the southern Quesnel Trough with similarities to the Copper Mountain porphyry deposit; and Filion, an underexplored gold-bearing greenstone belt adjacent to the Trans-Canada Highway in northern Ontario

TMET insiders are holding tight, controlling about 40% of the company's outstanding shares as the stock enters a new uptrend

The global market is experiencing a surge in demand for two key commodities: gold and copper. This trend presents a significant opportunity for Torr Metals (TSX.V: TMET), a mineral exploration company focused on developing its highly prospective district-scale gold and copper projects; where significant potential exists for major new discoveries located in highway-accessible, prolific mining jurisdictions of British Columbia and Ontario, Canada.

Torr Metals Inc. (TSX.V: TMET) operates as a mineral exploration company focusing on the identification, acquisition, and advancement of mineral properties. With full 100% ownership of over 1,000 square kilometers of gold and copper projects strategically positioned in premier low-cost mining jurisdictions, Torr is poised for substantial returns across various promising regions.

The company’s extensive portfolio encompasses multiple district-scale projects, including the Filion Gold Project in northern Ontario, the Kolos Copper-Gold Project in south-central British Columbia, and the Latham Copper-Gold Project in northern British Columbia. These projects are all located in prolific mining regions with paved highway access, robust support infrastructure, and favorable geological conditions offering significant potential for new discoveries.

Headquartered in Vancouver, British Columbia, Torr Metals is ideally situated to leverage its expertise and resources for continued exploration and growth.

Projects

Kolos Copper-Gold Project

Situated within British Columbia’s prime copper-producing belt, the 140-square-kilometer Kolos Copper-Gold Project exhibits Nicola Belt geology similar to notable porphyry mines, including Copper Mountain and Highland Valley, respectively situated 106 kilometers to the south and 30 kilometers to the northwest.

With field operations based in the nearby city of Merritt and year-round access provided via Highway 5, the Kolos Project showcases substantial discovery upside potential with five defined large-scale copper-gold-molybdenum anomalies untested by drilling.

Torr Metals’ primary focus lies in unlocking the potential for major new discoveries at the Kolos Copper-Gold Project, with recent surface geochemical results marking a significant milestone positioning the company as a new key player in the region.

Filion Gold Project

The 261-square-kilometer Filion Project is situated within a largely unexplored greenstone belt where gold was initially discovered in the 1930s. With a comparable geological setting to regional orogenic gold deposits and multiple newly identified and undrilled gold trends in surficial geochemistry, the Filion Project holds significant district-scale exploration promise.

The Filion Project benefits from unparalleled infrastructure access, with direct drive-on access from the Trans-Canada Highway, as well as a regional railway and power grid four kilometers to the south. Additionally, the nearby town of Kapuskasing, with a population of 8,300, provides essential support services.

This strategic positioning ensures the Filion Project’s viability for cost-effective, year-round operations in an area poised for untapped discovery potential.

Latham Copper-Gold Project

Situated in British Columbia’s renowned Golden Triangle, the Latham Project spans a vast 689-square-kilometer district, offering immense potential for multiple major discoveries. Accessible year-round via Highway 37, just 20 kilometers south of the town of Dease Lake, the site is strategically located amidst established mining infrastructure, including the active Red Chris mine to the southeast and upcoming major porphyry projects at Schaft Creek and Galore Creek along-trend to the southwest.

Highlighted by the Gnat Pass copper-gold porphyry deposit dating back to the 1960s, the Latham Project presents a compelling opportunity for significant expansion and potential discovery. A non-compliant indicated resource at the Gnat Pass deposit includes 33 million tonnes at 0.39% copper, open beyond 200 meters vertical depth, alongside six drill-ready kilometer-scale copper-gold exploration targets.

Moreover, the Latham Project’s appeal corresponds to the region being an attractive destination for major asset acquisitions and takeovers. Recent transactions within a 40-kilometer radius include Newmont’s 2021 acquisition of the Saddle North copper-gold porphyry deposit for $311 million and Newcrest’s investment in the Red Chris copper-gold porphyry deposit in 2019 for $804 million, underscoring industry acknowledgment of the region’s potential.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 that the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Likewise, a report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Malcolm Dorsey, P.Geo., is President, CEO and Director of Torr Metals. He brings over a decade of expertise as a seasoned exploration geologist and project developer, having been pivotal in driving the success of numerous diverse projects across North, Central, and South America. His comprehensive background spans early-stage exploration through to resource development and project acquisitions. His academic credentials include an M.Sc. in Geology and Geophysics from the University of Calgary, where his research characterized the district-scale structural influences affecting copper and gold mineralizing events in western British Columbia. Prior to his current role, he served as Senior Geologist for Benchmark Metals, where his contributions were instrumental in advancing the company’s gold equivalent resource from approximately 80,000 ounces to a maiden resource estimate of 2.92 million ounces.

John Williamson, P. Geol., is Chairman and Director of Torr Metals. He is a mining executive and investor with more than 30 years of experience as a founder, promoter and leader in the formation, financing and operation of private and public companies with exploration and mining interests worldwide. On more than one occasion his team’s efforts have been recognized for excellence by being named to the TSX Venture 50. He holds a B.Sc. in Geology and is a registered Professional Geologist (P.Geol.) with the Association of Professional Engineers and Geoscientists (APEGA) and the Geological Association of Canada.

Torr Metals Inc. (TSX.V: TMET), closed Tuesday's trading session at $31.845, up 0.711575%, on 166 volume. The average volume for the last 3 months is 169 and the stock's 52-week low/high is $24.01/$31.90.

Recent News

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)

The QualityStocks Daily Newsletter would like to spotlight Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF).

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FSE: 9NH) today announced that it has mobilized a drill rig for its 2024 exploration program at the Duquesne West Gold Project in Quebec. According to the announcement, the 8,000 m drill program is set to commence by mid-May to follow up on the results of Emperor's initial 2023 drill campaign. "We are very excited to resume drilling at Duquesne West Gold Project and continue our success in 2024," said Emperor Metals CEO John Florek. "2023 was a transformative year for the company with the revelation of a significant open pit concept above a high-grade gold deposit. This gives Emperor the ability to add ounces more rapidly on this project due to the capability of adding potentially open pitable mineralization above the high-grade historical resource. Emperor is well funded with approximately $4 million in working capital and will advance the Duquesne West project towards an updated mineral resource. Gold prices continue to show strength, and we are confident that everything is now in place to give our shareholders the best chance of a successful upside on this project."

To view the full press release, visit https://ibn.fm/EqCAA

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) is an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. The Project has a 2011 historical mineral resource estimate of 727,000 ounces of Au at 5.42 g/t and an average thickness of 5.71 m*.

In 2023, with the use of AI (Artificial Intelligence), Emperor Metals created the first ever 3D mineralized and geological model, which illuminated the potential to add significant ounces to this deposit. Using these models, Emperor’s had a very successful 2023 drilling campaign of 8,579 m. In addition to laterally extending high grade zones by intercepting grades of 15.8 g/t Au over 10.8 meters, Emperor encountered intercepts of lower grade bulk tonnage in the host rocks (1.69 g/t Au over 25 m). This led to envisioning a different strategy of exploration and the revelation that a conceptual open-pit potentially overlies this high-grade gold deposit. Historic core sampling began (2,500 m) for discovering overlooked lower grade gold in the host rock around the high-grade lenses. Lower grade bulk tonnage gold improves the open-pit economics by reducing stripping ratios and adding overlooked incremental ounces for open pit mining.

Emperor Metals is set to begin a fully funded Phase II 8,000 m drilling program in May 2024. The company also plans on assaying an additional 8,000 m of historic core within the open pit model. Emperor is working toward producing an updated NI 43-101 Mineral Resource Estimate by Q1 2025.

The company is led by a dynamic group of resource sector professionals who have a strong record of success in evaluating and advancing mining projects from exploration through to production, attracting capital and overcoming adversity to deliver exceptional shareholder value.

Project

Emperor Metals has an option to earn 100% ownership of the Duquesne West Gold Project, a mineral claim package comprising 38 claims covering approximately 1,389 ha (3,432 acres) in Quebec.

The Duquesne West Gold Property is located 32 kilometers northwest of the city of Rouyn-Noranda and 10 kilometers east of the town of Duparquet. The property lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt in the Superior Province.

Emperor is targeting the potential multimillion-ounce resource in a combination of conceptual open pit and underground mining scenarios. A Phase I drill campaign and historical core sampling program was completed in 2023, which included resource confirmation and exploration drilling, focusing on delineating and growing the resource toward development.

The property hosts a historical inferred mineral resource estimate of 727,000 ounces of gold at a grade of 5.42 grams per ton (g/t) and average stope thickness of 5.71 m. The mineral resource estimate predates modern Canadian Institute of Mining guidelines, and a Qualified Person on behalf of Emperor Metals has not reviewed or verified the mineral resource estimate. Therefore, it is considered historical in nature and is reported solely to provide an indication of the magnitude of mineralization that could be present on the property. The gold system remains open for resource identification and expansion.

Reinterpretation of the existing geological model was created using artificial intelligence and machine learning. This AI model shows the opportunity for additional discovery of ounces by revealing gold trends unknown to previous workers and the potential to expand the resource along significant gold-endowed structural zones. Multiple scenarios exist to expand additional resources, which include:

  • Underground High-Grade Gold
  • Open Pit Bulk Tonnage Gold
  • Underground Bulk Tonnage Gold

The Duquesne West-Ottoman property straddles the Porcupine-Destor gold localizing fault several kilometers east of the town of Duparquet. A number of previous drill campaigns have outlined an inferred resource of 4.17 million tons grading 5.42 g/t of gold (cut) or 6.36 g/t (uncut), as reported in the NI 43-101 report titled “Technical Report and Mineral Resource Estimate Update for the Duquesne-Ottoman Property, Quebec, Canada.”

Emperor Metals is funded for an 8,000-meter drilling program focusing primarily on adding ounces to the current resource within and lateral to the open pit model. An additional 8,000 m of historical core sampling and assaying is included in the budget to help build incremental ounces in the open-pit environment.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, to be worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

In May 2024, the market price of gold was approximately $2,340 per ounce.

Management Team

John Florek, P.Geol., is President, CEO and Director of Emperor Metals. He has more than 35 years of technical and senior management experience with major and junior mining companies, including roles as founder, vice president and director. He has helped identify and develop significant asset value for mines and exploration projects from grass roots through development. He has worked for several major mineral producers, including BHP, Placer Dome, Barrick, Teck and Detour Gold/Kirkland Lake Gold/Agnico Eagle.

Sean Mager is CFO and Director of Emperor Metals. He has worked more than 30 years in the mining sector, including extensive experience in corporate development, stakeholder relations, regulatory, financial and operations.

Alex Horsley is Head of Corporate Development and Director of Emperor Metals. He has more than 20 years of experience in the mining sector and capital markets with a focus on finance, marketing, management, corporate development and communications. He is founder and former CEO of Emperor Metals. He has assisted in raising more than C$40 million for exploration and development mining companies.

*Power-Fardy and Breede, 2011. The Mineral Resource Estimate (MRE) constructed in 2011 is considered historical in nature as it was constructed prior to the most recent Canadian Institute of Mining and Metallurgy (CIM) standards (2014) and guidelines (2019) for mineral resources. In addition, the economic factors used to demonstrate reasonable prospects of eventual economic extraction for the MRE have changed since 2011. A qualified person has not done sufficient work to consider the MRE as current. Emperor is not treating the historical MRE as current. The reader is cautioned not to treat it, or any part of it, as a current MRE.

Emperor Metals Inc. (OTCQB: EMAUF), closed Tuesday's trading session at $0.10835, off by 7.7087%, on 183,264 volume. The average volume for the last 3 months is 82,324 and the stock's 52-week low/high is $0.0597/$0.14505.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.